1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Europe AI in Life Science Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Europe AI in Life Science Market, by Component
8.1.1. Hardware
8.1.1.1. Market Revenue and Forecast
8.1.2. Software
8.1.2.1. Market Revenue and Forecast
8.1.3. Services
8.1.3.1. Market Revenue and Forecast
9.1. Europe AI in Life Science Market, by Deployment Mode
9.1.1. On-premise
9.1.1.1. Market Revenue and Forecast
9.1.2. Cloud
9.1.2.1. Market Revenue and Forecast
10.1. Europe AI in Life Science Market, by Application
10.1.1. Research & Development
10.1.1.1. Market Revenue and Forecast
10.1.2. Sales & Marketing Support
10.1.2.1. Market Revenue and Forecast
10.1.3. Supply Chain Analytics
10.1.3.1. Market Revenue and Forecast
10.1.4. Patient Health & Experience
10.1.4.1. Market Revenue and Forecast
11.1. Europe AI in Life Science Market, by End-User
11.1.1. Pharmaceutical Companies
11.1.1.1. Market Revenue and Forecast
11.1.2. Biotechnology Companies
11.1.2.1. Market Revenue and Forecast
11.1.3. Medical Device & Diagnostics Firms
11.1.3.1. Market Revenue and Forecast
11.1.4. Contract Research Organizations (CROs)
11.1.4.1. Market Revenue and Forecast
12.2. Europe
12.2.1. Market Revenue and Forecast, by Component
12.2.2. Market Revenue and Forecast, by Deployment Mode
12.2.3. Market Revenue and Forecast, by Application
12.2.4. Market Revenue and Forecast, by End-User
13.1. IBM Corporation
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Microsoft Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Google LLC (Alphabet Inc.)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. SAS Institute Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. IQVIA Holdings Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Databricks, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Accenture plc
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Oracle Corporation
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Siemens Healthineers AG
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Bayer AG
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
